Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Specific genetic polymorphisms of IL10-592 AA and IL10-819 TT genotypes lead to the key role for inducing docetaxel-induced liver injury in breast cancer patients.
Liang X, Zhang J, Zhu Y, Lu Y, Zhou X, Wang Z, Yu J, Yan Y, Di L, Che L, Jiang H, Shao B, Wang X, Yang H, Lyerly HK, Ren J. Liang X, et al. Among authors: lyerly hk. Clin Transl Oncol. 2013 Apr;15(4):331-4. doi: 10.1007/s12094-012-0936-6. Epub 2012 Nov 10. Clin Transl Oncol. 2013. PMID: 23143946
Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences.
Ren J, Di L, Song G, Yu J, Jia J, Zhu Y, Yan Y, Jiang H, Liang X, Che L, Zhang J, Wan F, Wang X, Zhou X, Lyerly HK. Ren J, et al. Among authors: lyerly hk. Clin Transl Oncol. 2013 Oct;15(10):780-8. doi: 10.1007/s12094-013-1001-9. Epub 2013 Jan 29. Clin Transl Oncol. 2013. PMID: 23359185 Clinical Trial.
Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy.
Song G, Wang X, Jia J, Yuan Y, Wan F, Zhou X, Yang H, Ren J, Gu J, Lyerly HK. Song G, et al. Among authors: lyerly hk. Cancer Immunol Immunother. 2013 Jun;62(6):1123-30. doi: 10.1007/s00262-013-1424-8. Epub 2013 Apr 21. Cancer Immunol Immunother. 2013. PMID: 23604172 Free PMC article.
Continuous DC-CIK infusions restore CD8+ cellular immunity, physical activity and improve clinical efficacy in advanced cancer patients unresponsive to conventional treatments.
Zhao YJ, Jiang N, Song QK, Wu JP, Song YG, Zhang HM, Chen F, Zhou L, Wang XL, Zhou XN, Yang HB, Ren J, Lyerly HK. Zhao YJ, et al. Among authors: lyerly hk. Asian Pac J Cancer Prev. 2015;16(6):2419-23. doi: 10.7314/apjcp.2015.16.6.2419. Asian Pac J Cancer Prev. 2015. PMID: 25824775 Free article.
Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45).
Wang X, Ren J, Zhang J, Yan Y, Jiang N, Yu J, Di L, Song G, Che L, Jia J, Zhou X, Yang H, Lyerly HK. Wang X, et al. Among authors: lyerly hk. Clin Transl Oncol. 2016 Jan;18(1):82-7. doi: 10.1007/s12094-015-1339-2. Epub 2015 Aug 13. Clin Transl Oncol. 2016. PMID: 26266766 Clinical Trial.
306 results